Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 3230-3235, October 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tiffany, S. M.
Right arrow Articles by Jeffs, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tiffany, S. M.
Right arrow Articles by Jeffs, P. W.

Investigation of Structure-Function Relationships of Cytotoxic Quinones of Natural and Synthetic Origin1

Sylvia M. Tiffany, Doyle G. Graham2, F. Stephen Vogel, Malcolm W. Cass and Peter W. Jeffs

Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710 [S.M.T., D.G.G., F.S.V.], and Gross Chemical Laboratory, Department of Chemistry, Duke University, Durham, North Carolina 27706 [M.W.C., P.W.J.]

A sulfhydryl-arylating quinone from the mushroom Agaricus bisporus, with an absorption maximum at 490 nm, was demonstrated to inhibit DNA polymerase {alpha} purified from calf thymus. The "490 quinone" could be generated through tyrosinase-mediated oxidation of {gamma}-L-glutaminyl-4-hydroxybenzene or {gamma}-L-glutaminyl-3,4-dihydroxybenzene. However, when {gamma}-L-glutaminyl-3,4-dihydroxybenzene was oxidized to {gamma}-L-glutaminyl-3,4-benzoquinone (GBQ) with sodium periodate, the product had an absorption maximum ({lambda}max) at 440 nm rather than at 490 nm and demonstrated notably less sulfhydryl reactivity than did the 490 quinone. These properties defined that the 490 quinone is not GBQ, as had been suggested previously, but a product of the oxidation of GBQ by tyrosinase. Additional quinones with an {lambda}max at 440 nm, produced from the oxidation of the acetyl and benzoyl analogs of {gamma}-L-glutaminyl-4-hydroxybenzene and {gamma}-L-glutaminyl-3,4-dihydroxybenzene, demonstrated the necessity of the amino acid side chain in the genesis of a quinone with an {lambda}max at 490 nm. Quinones with an {lambda}max near 490 nm were obtained after oxidation of 2,4,5-trihydroxyphenylalanine and 2,4,5-trihydroxyphenylethylamine, but these were exceedingly weak sulfhydryl reagents. Thus, while the precise structure of the 490 quinone remains unknown, these studies distinguish it from GBQ and demonstrate that the sulfhydryl reactivity of the 490 quinone is much greater than that of model quinones with similar spectral properties.

1 This investigation was supported by Grant CA-19013 awarded by the National Cancer Institute, Department of Health, Education and Welfare, and by a North Carolina United Community Services grant.

2 To whom requests for reprints should be addressed.

Received 3/ 6/78. Accepted 7/10/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.